Search results
Utah mom sues AstraZeneca, claiming she was left ‘permanently disabled’ inCOVID vaccine trial
New York Post· 2 days agoA Utah mother who says she was “permanently disabled” after taking part in the US clinical trial of ...
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 2 days agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
AstraZeneca's COVID prevention drug meets primary goals in late-stage study
Reuters· 2 hours agoAstraZeneca's investigational COVID-19 prevention therapy met its primary goals in a late-stage ...
AstraZeneca withdraws Covid-19 vaccine, citing low demand - Boston News, Weather, Sports | WHDH...
7 News Boston· 7 days agoAstraZeneca is withdrawing its highly successful coronavirusvaccine, citing the availability of a...
Mom suffers ‘disabling pain’ after COVID shot trial, suit says. She’s suing AstraZeneca
Miami Herald via Yahoo News· 2 days agoA Utah mother is suing AstraZeneca after she participated in a clinical trial for the company’s ...
AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher...
Medical Xpress· 7 days agoAstraZeneca on March 27, 2024, to withdraw the EU marketing authorization. This development has been...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 6 days agoAstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator ...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can...
3 Biotech Stocks to Sell in May Before They Crash & Burn
InvestorPlace· 6 days agoAlthough 5% up over one year, the S&P Biotechnology Select Industry Index is down .22% year-to-date....